NSECopy of Newspaper Publication3h ago · 31 Oct 2026, 11:52 am

Copy of Newspaper Publication

CORONA Remedies Limited · CORONA

✦ AI SummaryResults

CORONA Remedies Limited has announced the publication of unaudited financial results for the second quarter and half year ended September 30, 2026, with revenue from operations at ₹35,875.05 lakhs and net profit for the period at ₹1,339.37 lakhs.

Analysis Scores

Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

CORONA Remedies Limited has informed the Exchange about Copy of Newspaper Publication

Attachments (1)

📄

CORONAREMEDIES_31102026115204_Newspaper_Publication_regarding_Unaudited_Financial_Results.pdf

pdf

Download →
View document text
October 31, 2026 To, To, Listing Operation Department Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Bandra Kurla Dalal Street, Mumbai-400001 Complex, Bandra (East), Mumbai-400051 (Scrip Code: 544644) (SYMBOL: CORONA) Dear Sir / Madam, Sub.: Newspaper Publication of Unaudited Financial Results for the second quarter and half year ended on September 30, 2026 Kindly note that the Board of Directors, at its meeting held on Friday, October 30, 2026 had considered and approved the Unaudited Financial Results of the Company (Standalone and Consolidated) for the second quarter and half year ended on September 30, 2026. Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the newspaper advertisement of the Unaudited Financial Results, published today in Financial Express (English and Gujarati). The extract of aforesaid newspaper publication is also being made available on the website of the Company at www.coronaremedies.com You are requested to take note of the above. Thanking you. Yours faithfully, For CORONA Remedies Limited Chetna Dharajiya Company Secretary and Compliance Officer Encl.: A/a INDIGO PAINTS LIMITED INDIGO RegisteredOffice:IndigoTower,Street-5,PallodFarm-2, Besurprised! BanerRoad,Pune,Maharashtra-411045 Corporate Identity Number: L24114PN2000PLC014669 Extract of consolidated and standalone undudited financial results for the quarter and six months ended September 30, 2026 (All amounts in INR lakhs, unless otherwise stated) Consolidated Sr. Quarter ended Six months ended Year ended Particulars Sep 30, 2026 Jun 30, 2026 Sep 30, 2025 Sep 30, 2026 Sep 30, 2025 Mar 31, 2026 (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) 1 Revenue from operations 35,875.05 36,967.08 31,205.91 72,842.13 62,092.30 1,40,501.68 2 Netprofitfortheperiodbeforeexceptionalitems* 1,665.63 5,603.21 3,376.57 7,268.84 6,851.99 20,459.19 3 Netprofitfortheperiodbeforetax* 1,665.63 5,603.21 3,376.57 7,268.84 6,851.99 19,845.88 4 Netprofitfortheperiodaftertax* 1,339.37 4,170.32 2,524.96 5,509.69 5,130.73 14,760.77 5 Totalcomprehensiveincomefortheperiod 1,331.16 4,162.10 2,521.66 5,493.26 5,124.14 14,727.91 6 Equitysharecapital 4,773.27 4,767.57 4,767.57 4,773.27 4,767.57 4,767.57 7 Reservesexcludingrevaluationreservesasat 1,10,629.10 BalanceSheetdate 8 EarningsPerShare (FaceValueofINR10/-each)(not annualised) -Basic(FaceValueofINR10/-each) 2.80 8.76 5.27 11.56 10.71 30.44 -Diluted(FaceValueofINR10/-each) 2.80 8.72 5.26 11.52 10.68 30.34 * There are no extraordinary items in any of the period disclosed above. Note: 1) TheaboveisanextractofthedetailedformatofunauditedfinancialresultsfiledwiththeStockExchangesunderRegulation33oftheSEBI(ListingObligationand DisclosureRequirements)Regulations,2015.ThefullformatoftheunauditedfinancialresultsisavailableontheStockExchangewebsites(URL:https://www. nseindia.com,https://www.bseindia.com)andalsoontheCompany’swebsite(URL:https://www.indigopaints.com).Thesamecanbeaccessedbyscanningthe QR code provided below. 2) KeyfinancialfiguresforIndigoPaintsLimited(standalone)areasfollows: Quarter ended Six months ended Year ended No. Particulars Sep 30, 2026 Jun 30, 2026 Sep 30, 2025 Sep 30, 2026 Sep 30, 2025 Mar 31, 2026 (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) 1 Revenue from operations 34,048.45 35,004.54 29,850.18 69,052.99 59,335.40 1,33,011.82 2 Netprofitfortheperiodbeforeexceptionalitems* 1,723.36 5,692.93 3,413.64 7,416.29 6,931.21 20,112.36 3 Netprofitfortheperiodbeforetax* 1,723.36 5,692.93 3,413.64 7,416.29 6,931.21 19,527.03 4 Netprofitfortheperiodaftertax* 1,380.80 4,236.53 2,553.31 5,617.33 5,189.04 14,538.78 5 Totalcomprehensiveincomefortheperiod 1,370.00 4,225.74 2,547.55 5,595.74 5,177.53 14,495.62 6 Equitysharecapital 4,773.27 4,767.57 4,767.57 4,773.27 4,767.57 4,767.57 7 Reservesexcludingrevaluationreservesasat 1,13,467.22 BalanceSheetdate 8 EarningsPerShare (FaceValueofINR10/-each)(not annualised) -Basic(FaceValueofINR10/-each) 2.90 8.89 5.36 11.79 10.89 30.51 -Diluted(FaceValueofINR10/-each) 2.90 8.85 5.35 11.75 10.86 30.41 For Indigo Paints Limited Sd/- Hemant Jalan Chairman & Managing Director Place : Pune DIN : 00080942 Date : October 30, 2026